GSK China Investment Co. Ltd (GSKCI), the British drugmaker, is fined 3 billion yuan for its bribe. This is the biggest fine in Chinese history. ANBOUND think tank scholars believe that the huge fine on GSKCI shows Chinese government is resolute to maintain the normal market order. Antitrust isn't the only way to maintain that order and foreign-funded enterprises are not the only targets. For foreign-funded enterprises, the "super-preferential policies" in Chinese market have disappeared and they mustn’t make money in Chinese market and harm the Chinese market in return.